The Barrett Lab studies the immune function of children with cancer. This research program takes two paths: investigating possible immune deficiencies that result in children developing cancer and developing immune-based therapies for childhood cancer.
The Children's Hospital of Philadelphia's groundbreaking leukemia research was on display at the recent American Society of Hematology (ASH) Annual Meeting. Held in New Orleans, the ASH Annual Meeting brought together approximately 20,000 researchers, clinicians, and industry representatives, with data from more than 5,300 abstracts presented.
The investigators, Stephen A. Grupp, MD, PhD and Carl H. June, MD, engineered T cells - the workhorses of the immune system, which recognized and attack invading disease cells - to selectively kill another type of immune cell called B cells, which had become cancerous.
According to new research from The Children's Hospital of Philadelphia and the University of Pennsylvania,
The end of the year has come up fast, and so have important advances in pediatric research at Children's Hospital of Philadelphia. This week's In the News starts off with a celebration of two remarkable patients and their dedicated pediatric oncologist.
Super Bowl Sunday is right around the corner, and our biweekly installment of In the News is the perfect playing field for us to showcase the wide range of research projects that Children's Hospital of Philadelphia experts tackle. Huddle up!